Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482 · cited 1×
“3 months longer than those treated with usual care [103].”
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
Ginsberg, R. J., & Rubinstein, L. V. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00537-u · Cited by 3,006
Comprehensive geriatric assessment: a meta-analysis of controlled trials
Stuck, A. E., Siu, A. L., Wieland, G. D., Rubenstein, L. Z., & Adams, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)92884-v · Cited by 1,974 · cited 1×
“A meta-analysis of 28 controlled trials not restricted to cancer patients (4959 subjects allocated to one of five CGA types and 4912 controls) demonstrated that CGA, if linked to proper geriatric interventions, reduced early re-hospitalization and mortality in older patients through early identification and treatment…”
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7625 · Cited by 1,841 · cited 1×
“CGA domains can predict the risk of chemotherapy toxicity [108, 109].”
Extermann, M., Boler, I., Reich, R. R., Lyman, G. H., Brown, R. H., DeFelice, J., Levine, R. M., Lubiner, E. T., Reyes, P., Schreiber, F. J., et al. (2012) · Cancer · doi:10.1002/cncr.26646 · Cited by 1,143
Screening older cancer patients: first evaluation of the G-8 geriatric screening tool
Bellera, C. A., Rainfray, M., Mathoulin-Pélissier, S., Mertens, C., Delva, F., Fonck, M., & Soubeyran, P. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr587 · Cited by 1,132 · cited 1×
“VES-13 [110, 111], G8 [112], GFI [113]) to screen older patients for potential problems, who require a full CGA [70].”
Use of comprehensive geriatric assessment in older cancer patients:
Extermann, M., Aapro, M., Bernabei, R., Cohen, H. J., Droz, J.-P., Lichtman, S., Mor, V., Monfardini, S., Repetto, L., Sørbye, L., et al. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.06.003 · Cited by 1,098
The Vulnerable Elders Survey: A Tool for Identifying Vulnerable Older People in the Community
Saliba, D., Elliott, M., Rubenstein, L. Z., Solomon, D. H., Young, R. T., Kamberg, C. J., Carol Roth, R., MacLean, C. H., Shekelle, P. G., Sloss, E. M., et al. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49281.x · Cited by 1,073 · cited 2×
“For that reason, several abbreviated screening tools have been developed (e.g. VES-13 [110, 111], G8 [112], GFI [113]) to screen older patients for potential problems, who require a full CGA [70].”
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Walter, L. C., & Covinsky, K. E. (2001) · JAMA · doi:10.1001/jama.285.21.2750 · Cited by 1,003 · cited 1×
“There is limited information regarding the preferences of the elderly for deciding to undergo screening, the process of being screened and the health status associated with being or not being screened [20].”
Xu, Y., Liu, H., Chen, J., & Zhou, Q. (2010) · Thoracic Cancer · doi:10.1111/j.1759-7714.2010.00016.x · Cited by 884
Socinski, M. A., Bondarenko, I., Karaseva, N. A., Makhson, A. M., Vynnychenko, I., Okamoto, I., Hon, J. K., Hirsh, V., Bhar, P., Zhang, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5848 · Cited by 756 · cited 1×
“A recent phase III trial randomly assigned 1052 NSLCC patients to carboplatin (AUC6, day 1 q 3 weeks) and either nab-paclitaxel (100 mg/m(2) weekly [nab-P/C]) or solvent-based paclitaxel (200 mg/m(2) day 1 q 3 weeks [sb-P/C]) [82].”
Walter, L. C. (2001) · JAMA · doi:10.1001/jama.285.23.2987 · Cited by 674
Allen, M. S., Darling, G. E., Pechet, T. T. V., Mitchell, J. D., Herndon, J. E., Landreneau, R. J., Inculet, R. I., Jones, D. R., Meyers, B. F., Harpole, D. H., et al. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.06.066 · Cited by 672
Jaklitsch, M. T., Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S., MacMahon, H., Mulshine, J. L., Munden, R. F., Salgia, R., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.05.060 · Cited by 608 · cited 1×
“Based on these data, the American Association of Thoracic Surgery (AATS) recommends annual screening up to the age of 79 [17, 18].”
Self-citationWeight Change in Old Age and its Association with Mortality
Newman, A. B., Yanez, D., Harris, T., Duxbury, A., Enright, P. L., Fried, L. P., & for the Cardiovascular Study Research Group (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49258.x · Cited by 566 · cited 1×
“Weight loss is known to be a negative prognostic factor for OS in NSCLC [78] and low BMI is associated with an increased risk of mortality [79].”
Quoix, E., Zalcman, G., Oster, J.-P., Westeel, V., Pichon, E., Lavolé, A., Dauba, J., Debieuvre, D., Souquet, P.-J., Bigay-Game, L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60780-0 · Cited by 566
Prognostic Factors for Survival in Patients With Inoperable Lung Cancer 2
(1980) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/65.1.25 · Cited by 564 · cited 1×
“Weight loss is known to be a negative prognostic factor for OS in NSCLC [78] and low BMI is associated with an increased risk of mortality [79].”
Inoue, A., Kobayashi, K., Usui, K., Maemondo, M., Okinaga, S., Mikami, I., Ando, M., Yamazaki, K., Saijo, Y., Gemma, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7658 · Cited by 505 · cited 2×
“that enrolled very old (>80 years) patients or patients with PS 3–4 and demonstrated significant benefit even for these patients [90].”
Palma, D., Visser, O., Lagerwaard, F. J., Belderbos, J., Slotman, B. J., & Senan, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0731 · Cited by 479 · cited 1×
“A population-based study from the Netherlands demonstrated that the introduction of SABR was associated with an increase in RT use, a reduction in the proportion of untreated elderly and an improvement in OS [57].”
Caillet, P., Canoui-Poitrine, F., Vouriot, J., Berle, M., Reinald, N., Krypciak, S., Bastuji-Garin, S., Culine, S., & Paillaud, E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.0664 · Cited by 426 · cited 1×
“It can also reveal previously unknown geriatric problems, if followed by targeted interventions can improve QoL and compliance to therapy [106, 107].”
Mulshine, J. L., & Sullivan, D. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042630 · Cited by 419
EORTC elderly task force position paper: Approach to the older cancer patient
Pallis, A. G., Fortpied, C., Wedding, U., Van Nes, M. C., Penninckx, B., Ring, A., Lacombe, D., Monfardini, S., Scalliet, P., & Wildiers, H. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.022 · Cited by 340 · cited 14×
“* Correspondence to: Dr Athanasios G. Pallis, Elderly Task Force - European Organization for Research and Treatment of Cancer (EORTC), Avenue E. Mounier 83/11, 1200 Brussels, Belgium.”
MethodInfluentialSelf-citationKenis, C., Bron, D., Libert, Y., Decoster, L., Van Puyvelde, K., Scalliet, P., Cornette, P., Pepersack, T., Luce, S., Langenaeken, C., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds619 · Cited by 338 · cited 2×
“(n = 1967 cancer patients, ≥70 years old) demonstrated that CGA in older patients with cancer is feasible for large numbers in busy clinics, and has a significant impact on the detection of unknown geriatric problems, leading to geriatric interventions and adapted treatment [80].”
Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review
Puts, M. T. E., Hardt, J., Monette, J., Girre, V., Springall, E., & Alibhai, S. M. H. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs285 · Cited by 335 · cited 1×
“Six of nine studies reported an association of results of CGAwith toxicity of chemotherapy, 8 out of 16 studies reported an association with mortality, and two of four studies reported a change of treatment recommendations after knowledge of results in 40%–50% of patients [115].”
Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
Davidoff, A. J., Tang, M., Seal, B., & Edelman, M. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4052 · Cited by 290 · cited 1×
“This could be the reason for the significant under-treatment of elderly patients in clinical practice [28, 73].”
Use of Video-Assisted Thoracic Surgery for Lobectomy in the Elderly Results in Fewer Complications
Cattaneo, S. M., Park, B. J., Wilton, A. S., Seshan, V. E., Bains, M. S., Downey, R. J., Flores, R. M., Rizk, N., & Rusch, V. W. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.080 · Cited by 271
Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review
Senthi, S., Haasbeek, C. J. A., Slotman, B. J., & Senan, S. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.01.004 · Cited by 259 · cited 1×
“It should be noted that most of the available evidence to support SABR is in patients with peripheral tumours and that there is paucity of prospective multicentre data in patients with central tumours [56].”
Shirvani, S. M., Jiang, J., Chang, J. Y., Welsh, J. W., Gomez, D. R., Swisher, S., Buchholz, T. A., & Smith, B. D. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.07.2354 · Cited by 250
Atagi, S., Kawahara, M., Yokoyama, A., Okamoto, H., Yamamoto, N., Ohe, Y., Sawa, T., Ishikura, S., Shibata, T., Fukuda, H., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70139-0 · Cited by 239
Luciani, A., Ascione, G., Bertuzzi, C., Marussi, D., Codecà, C., Di Maria, G., Caldiera, S. E., Floriani, I., Zonato, S., Ferrari, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9978 · Cited by 195 · cited 2×
“For that reason, several abbreviated screening tools have been developed (e.g. VES-13 [110, 111], G8 [112], GFI [113]) to screen older patients for potential problems, who require a full CGA [70].”
Self-citationVulnerability in the Elderly: Frailty
Slaets, J. P. J. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.05.008 · Cited by 193 · cited 2×
“For that reason, several abbreviated screening tools have been developed (e.g. VES-13 [110, 111], G8 [112], GFI [113]) to screen older patients for potential problems, who require a full CGA [70].”
Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients?
Girre, V., Falcou, M.-C., Gisselbrecht, M., Gridel, G., Mosseri, V., Bouleuc, C., Poinsot, R., Vedrine, L., Ollivier, L., Garabige, V., et al. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.7.724 · Cited by 188 · cited 1×
“It can also reveal previously unknown geriatric problems, if followed by targeted interventions can improve QoL and compliance to therapy [106, 107].”
Impact of Age and Comorbidity on Non–Small-Cell Lung Cancer Treatment in Older Veterans
Wang, S., Wong, M. L., Hamilton, N., Davoren, J. B., Jahan, T. M., & Walter, L. C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5269 · Cited by 176 · cited 5×
“However, the likelihood of elderly patients with early-stage disease not receiving any treatment significantly increases with age [28].”
InfluentialEstimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer: A Cohort Study
Veronesi, G., Maisonneuve, P., Bellomi, M., Rampinelli, C., Durli, I., Bertolotti, R., & Spaggiari, L. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00005 · Cited by 162
Self-citationPalma, D., Visser, O., Lagerwaard, F. J., Belderbos, J., Slotman, B., & Senan, S. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.029 · Cited by 159
Maemondo, M., Minegishi, Y., Inoue, A., Kobayashi, K., Harada, M., Okinaga, S., Morikawa, N., Oizumi, S., Tanaka, T., Isobe, H., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318260de8b · Cited by 159
Pallis, A. G., Gridelli, C., van Meerbeeck, J. P., Greillier, L., Wedding, U., Lacombe, D., Welch, J., Belani, C. P., & Aapro, M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp360 · Cited by 151 · cited 2×
“The same selection criteria were applied as in the previous publication [4].”
MethodSelf-citationOkami, J., Ito, Y., Higashiyama, M., Nakayama, T., Tokunaga, T., Maeda, J., & Kodama, K. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.06.090 · Cited by 132
The illness trajectory of elderly cancer patients across cultures: SIOG position paper
Surbone, A., Kagawa‐Singer, M., Terret, C., & Baider, L. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl178 · Cited by 129 · cited 1×
“Elderly NSCLC patients want to be involved in the decision making and also need to involve family members in the processes of diagnosis and prognosis disclosure and decision making, and this should be respected and taken into account by treating physicians [99, 100].”
Sharma, D. B. (2012) · JAMA · doi:10.1001/jama.2012.454 · Cited by 128
Port, J. L., Mirza, F. M., Lee, P. C., Paul, S., Stiles, B. M., & Altorki, N. K. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.06.082 · Cited by 120
Sacher, A. G., Le, L. W., Leighl, N. B., & Coate, L. E. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827e2145 · Cited by 116 · cited 1×
“However, despite the high incidence of lung cancer in the elderly, it is known that these patients are under-represented in clinical trials and, therefore, it is difficult to reach evidence-based clinical recommendations for them [2].”
Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S. H., MacMahon, H., Mulshine, J. L., Munden, R. F., Salgia, R., Strauss, G. M., et al. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.05.059 · Cited by 111 · cited 1×
“Based on these data, the American Association of Thoracic Surgery (AATS) recommends annual screening up to the age of 79 [17, 18].”
Self-citationOlder Adults and Forgoing Cancer Screening
Torke, A. M., Schwartz, P. H., Holtz, L. R., Montz, K., & Sachs, G. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.2903 · Cited by 111 · cited 1×
“screening may include discussion of the balance of risks and benefits, complications or burdens [22].”
Socinski, M. A., Langer, C. J., Okamoto, I., Hon, J. K., Hirsh, V., Dakhil, S. R., Page, R. D., Orsini, J., Zhang, H., & Renschler, M. F. (2013) · Annals of Oncology · doi:10.1093/annonc/mds461 · Cited by 108
Communicating cancer diagnosis and prognosis: When the target is the elderly patient-a GIOGer study
Repetto, L., Piselli, P., Raffaele, M., & Locatelli, C. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.08.020 · Cited by 95 · cited 1×
“Although clinical information is very important for older cancer patients, a significant proportion of them do not receive enough information [98].”
Jennens, R. R., Giles, G. G., & Fox, R. M. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01033.x · Cited by 90 · cited 1×
“The median age at diagnosis of lung cancer is ∼71 years [14].”
Cuffe, S. D., Booth, C. M., Peng, Y., Darling, G. E., Li, G., Kong, W., Mackillop, W. J., & Shepherd, F. A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.3330 · Cited by 88 · cited 2×
“The cisplatin/vinorelbine combination was the most frequently used doublet across all age groups; however, a trend in the use of carboplatin-based regimens as carboplatin plus paclitaxel was seen for elderly patients [60].”
Surgical Management and Outcomes of Elderly Patients With Early Stage Non-small Cell Lung Cancer
Rivera, C., Falcoz, P., Bernard, A., Thomas, P. A., & Dahan, M. (2011) · CHEST Journal · doi:10.1378/chest.10-2841 · Cited by 85
Pallis, A. G., Wedding, U., Lacombe, D., Soubeyran, P., & Wildiers, H. P. M. W. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.01.006 · Cited by 82 · cited 18×
“A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly.”
InfluentialSelf-citationLewis, C. L., Kistler, C. E., Amick, H. R., Watson, L. C., Bynum, D. L., Walter, L. C., & Pignone, M. P. (2006) · BMC Geriatrics · doi:10.1186/1471-2318-6-10 · Cited by 82 · cited 1×
“A small study assessed the attitudes towards screening of 116 older adults [21].”
Wisnivesky, J. P., Halm, E. A., Bonomi, M. R., Powell, C. A., & Bagiella, E. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1064oc · Cited by 78 · cited 1×
“A recent report based on the SEER registry with data from more than 6000 patients demonstrated that use of RT resulted in overall and lung cancerspecific survival improvement compared with untreated patients [54].”
Davidoff, A. J., Gardner, J. F., Seal, B. S., & Edelman, M. J. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820eed00 · Cited by 75 · cited 2×
“Patients who received combined modality treatment [chemoradiotherapy (CMRT) either sequentially or concurrently] had better survival compared with patients who received single modality treatment [64–66], but at the cost of higher toxicity and mortality [66].”
Laskin, J. J., Crinò, L., Felip, E., Franke, F. A., Горбунова, В. А., Groen, H. J. M., Jiang, G.-L., Reck, M., & Schneider, C.-P. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182370e02 · Cited by 72 · cited 1×
“A pre-planned age-specific subgroup analysis was carried out in patients older than 65 years (n = 623) [86].”
Patients’ preferences for chemotherapy in non-small-cell lung cancer: A systematic review
Blinman, P. L., Alam, M., Duric, V. M., McLachlan, S., & Stockler, M. R. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.05.001 · Cited by 68
van der Drift, M. A., Karim‐Kos, H. E., Siesling, S., Groen, H. J. M., Wouters, M. W. J. M., Coebergh, J. W. W., de Vries, E., & Janssen-Heijnen, M. L. G. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823a01fb · Cited by 67 · cited 1×
“However, population-based data from the Netherlands demonstrated that the number of elderly NSCLC patients undergoing surgical resection increased between 1989 and 2009 [30] and, in addition, the authors noted an improvement in median survival between 2001 and 2009 [31].”
Chambers, A., Routledge, T., Pilling, J. E., & Scarci, M. (2010) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2010.233189 · Cited by 66
Chen, Y.-M., Tsai, C., Fan, W.-C., Shih, J.-F., Liu, S.-H., Wu, C.-H., Chou, T., Lee, Y.-C., Perng, R.-P., & Whang‐Peng, J. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823a39e8 · Cited by 62 · cited 1×
“Similarly, a randomized phase II trial of erlotinib versus vinorelbine in elderly (70 years or older) demonstrated a significant OS benefit in the EGFR mutation-positive sub-population [92].”
Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit
Rivera, C., Dahan, M., Bernard, A., Falcoz, P., & Thomas, P. A. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.09.022 · Cited by 59
Coate, L. E., Massey, C., Hope, A. J., Sacher, A. G., Barrett, K., Pierre, A. F., Leighl, N. B., Brade, A. M., de Perrot, M. E., Waddell, T. K., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820b8b9b · Cited by 56
Blanchard, E. M., Arnaoutakis, K., & Hesketh, P. J. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d89b48 · Cited by 56
Asami, K., Koizumi, T., Hirai, K., Ameshima, S., Tsukadaira, A., Morozumi, N., Morikawa, A., Atagi, S., & Kawahara, M. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.02.004 · Cited by 51
Stinchcombe, T. E., Roder, J., Peterman, A. H., Grigorieva, J., Lee, C. B., Moore, D. T., & Socinski, M. A. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182835577 · Cited by 50 · cited 1×
“A retrospective analysis of VeriStrat status of this trial demonstrated that gemcitabine was superior in patients with VeriStrat poor status, while, in patients with VeriStrat good status, erlotinib might be an option and warrants further investigation [94].”
Leprieur, E. G., Labrune, S., Giraud, V., Gendry, T., Cobarzan, D., & Chinet, T. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.11.010 · Cited by 49 · cited 2×
“Time between initial symptoms, diagnosis and start of treatment is similar between younger and older patients [6].”
Postoperative radiotherapy for elderly patients with stage III lung cancer
Wisnivesky, J. P., Halm, E. A., Bonomi, M. R., Smith, C. B., Mhango, G., & Bagiella, E. (2012) · Cancer · doi:10.1002/cncr.26585 · Cited by 47
Gironés, R., Torregrosa, D., Gómez‐Codina, J., Maestu, I., Tenías, J. M., & Rosell, R. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0782-6 · Cited by 46 · cited 3×
“Elderly NSCLC patients want to be involved in the decision making and also need to involve family members in the processes of diagnosis and prognosis disclosure and decision making, and this should be respected and taken into account by treating physicians [99, 100].”
Cheng, Y., Duan, C., Dong, S., Zhang, H., Zhang, S. K., Wang, S. Q., & Zhang, C. F. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.08.001 · Cited by 40
Radiotherapy for lung cancer in the elderly
Bayman, N., Alam, N. S., & Finn, C. F. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.12.004 · Cited by 39 · cited 1×
“Despite a concerted effort to remove age cut-off from inclusion criteria in clinical trials, evidence to support CMRT (particularly concurrent CTRT) in the elderly is limited [67].”
Non-small Cell Lung Cancer in Octogenarians: Treatment Practices and Preferences
Oxnard, G. R., Fidias, P. M., Muzikansky, A., & Sequist, L. V. D. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318158d4a2 · Cited by 38 · cited 1×
“The majority of elderly patients expect to receive aggressive treatment although a small but clinically significant portion chose not to receive the offered treatment [99, 102].”
Gridelli, C., Brodowicz, T., Langer, C. J., Peterson, P. M., Islam, M., Guba, S. C., Moore, P., Visseren‐Grul, C., & Scagliotti, G. V. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.12.002 · Cited by 37
Self-citationStinchcombe, T. E., Peterman, A. H., Lee, C. B., Moore, D. T., Beaumont, J. L., Bradford, D. S., BAKRI, K. M., Taylor, M., Crane, J. M., Schwartz, G. H., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182210430 · Cited by 36
Wanders, R., Steevens, J., Botterweck, A. A. M., Dingemans, A. C., Reymen, B. J. T., van Baardwijk, A. A. W., Borger, J. H., Bootsma, G. P., Pitz, C. C. M., Lunde, R., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.023 · Cited by 35
Park, S., Kim, I. R., Baek, K. K., Lee, S. J., Chang, W. J., Maeng, C. H., Hong, J. Y., Choi, M., Kim, Y. S., Sun, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds649 · Cited by 35 · cited 1×
“No difference in quality of life (QoL) between elderly and nonelderly patients receiving adjuvant chemotherapy has been documented [61].”
Wozniak, A. J., Garst, J. L., Jahanzeb, M., Kosty, M. P., Vidaver, R. M., Beatty, S., Teng, S., Flick, E. D., Sing, A., Lynch, T. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.7618 · Cited by 34 · cited 1×
“ARIES is another phase IV trial assessing bevacizumab efficacy and safety among a broader population of NSCLC patients in a real-world setting [87].”
Spigel, D. R., Hainsworth, J. D., Shipley, D. L., Ervin, T. J., Kohler, P. C., Lubiner, E. T., Peyton, J. D., Waterhouse, D. M., Burris, H. A., & Greco, F. A. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182307efe · Cited by 29 · cited 1×
“Finally, a small randomized phase II study compared a platinum-containing doublet (carboplatin/pemetrexed) versus a platinum-free doublet (pemetrexed/gemcitabine) in 110 elderly (≥70 years) NSCLC patients [84].”
Nonreferral of Nursing Home Patients With Suspected Breast Cancer
Hamaker, M. E., Hamelinck, V. C., Munster, B. C. V., Bastiaannet, E., Smorenburg, C. H., Achterberg, W. P., Liefers, G., & de Rooij, S. E. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.01.002 · Cited by 29 · cited 1×
“demonstrated insufficient sensitivity and specificity for those screening instruments [114].”
Karampeazis, A., Vamvakas, L. N., Agelidou, A., Kentepozidis, N. K., Chainis, K., Chandrinos, V., Vardakis, N., Pallis, A. G., Christophyllakis, C., & Georgoulias, V. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.03.015 · Cited by 25 · cited 1×
“A prospective phase III trial compared single-agent docetaxel to single-agent vinorelbine in patients older than 65 years and failed to demonstrate any difference between the two treatments [76].”
Self-citationClinical Outcomes and Biomarker Profiles of Elderly Pretreated NSCLC Patients from the BATTLE Trial
Tsao, A. S., Liu, S., Lee, J. J., Alden, C. M., Blumenschein, G. R., Herbst, R. S., Davis, S. E., Kim, E. J.-H., Lippman, S. M., Stewart, D., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826910ff · Cited by 23 · cited 1×
“Biomarker expression was also compared between younger and older patients participating in the BATTLE programme [12].”
Wu, C., Fan, W.-C., Chen, Y., Chou, K., Shih, J.-F., Tsai, C., Lee, Y., & Perng, R.-P. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181cee2d4 · Cited by 22 · cited 1×
“retrospectively reviewed and analysed data of 293 young (<70 years), and 168 patients (≥70 years) who were treated with second-line treatment (both chemotherapy and EGFR TKIs) in the context of clinical trials of their department [97].”
Are we treating enough elderly patients with early stage non-small cell lung cancer?
Pallis, A. G., & Scarci, M. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.05.025 · Cited by 20 · cited 2×
“Elderly patients are more likely to be diagnosed with stage I disease but, most probably, this is because elderly seek more frequently medical consultation because of coexisting medical problems or because of understaging due to more conservative staging, and not because of differences in the biology of the disease [9…”
Self-citationBillmeier, S. E., Ayanian, J. Z., He, Y., Jaklitsch, M. T., & Rogers, S. O. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31828353af · Cited by 20 · cited 2×
“The risk of nursing home admission, severe functional impairment or death was low (16%) for patients younger than 75 years and for those 75 years or older with stage I disease; intermediate (33%) for patients 75 years or older with stage II– IIIA disease and no or mild comorbidities; high (60%) for those 75 years or o…”
Self-citationMerimsky, O., CHENG, C.-K., Au, J. S. K., von Pawel, J., & Reck, M. (2012) · Oncology Reports · doi:10.3892/or.2012.1824 · Cited by 18
Zhu, J., Sharma, D. B., Chen, A. B., Johnson, B. E., Weeks, J. C., & Schrag, D. (2013) · Cancer · doi:10.1002/cncr.28022 · Cited by 17 · cited 1×
“A retrospective series with 15 318 Medicare patients who received first-line treatment observed a moderate OS benefit associated with the use of carboplatin–paclitaxel doublet versus carboplatin combined with either gemcitabine or docetaxel [74].”
Riggs, H., Jalal, S. I., Baghdadi, T. A., Bhatia, S., McClean, J., Johnson, C. S., Yu, M., Taber, D. A., Harb, W. A., & Hanna, N. H. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.09.004 · Cited by 15 · cited 1×
“A small, single-arm phase II study failed to demonstrate significant activity of the combination of erlotinib and bevacizumab in elderly or PS 2 patients with NSCLC [95].”
Mediastinal lymphadenectomy in elderly patients with non-small-cell lung cancer
Rivera, C., Falcoz, P., Rami–Porta, R., Velly, J.-F., Bégueret, H., Roques, X., Dahan, M., & Jougon, J. B. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs586 · Cited by 13 · cited 1×
“Elderly are also more likely to be diagnosed with squamous histology, although the reason for this difference is not quite clear [7, 8, 10] and more significant mediastinal lymph node involvement [11].”
Kawaguchi, T., Tamiya, A., Tamura, A., Arao, M., Saito, R., Matsumura, A., Ou, S. I., & Tamura, T. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.03.010 · Cited by 10
Cited by
Corre, R., Greillier, L., Le Caër, H., Audigier-Valette, C., Baize, N., Bérard, H., Falchero, L., Monnet, I., Dansin, E., Vergnenègre, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.5839 · Cited by 403
“Consequently, current guidelines recommend first-line treatment with a carboplatin-based doublet for fit elderly patients and consider that single-agent treatment is an option for less fit patients; no specific recommendations are made for octogenarians.(10) However, there is no consensus definition of fit or less fit…”
Scientific Advances in Lung Cancer 2015
Tsao, A. S., Scagliotti, G. V., Bunn, P. A., Carbone, D. P., Warren, G. W., Bai, C., de Koning, H. J., Yousaf-Khan, A. U., McWilliams, A., Tsao, M. S., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.03.012 · Cited by 284
Grossi, F., Crinò, L., Logroscino, A., Canova, S., Delmonte, A., Melotti, B., Proto, C., Gelibter, A., Cappuzzo, F., Turci, D., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.05.015 · Cited by 111
How to Implement a Geriatric Assessment in Your Clinical Practice
Sattar, S., Alibhai, S. M. H., Wildiers, H., & Puts, M. T. E. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0180 · Cited by 75
Metadata
- Authors
- Pallis, A. G., Gridelli, C., Wedding, U., Faivre-Finn, C., Veronesi, G., Jaklitsch, M., Luciani, A., & O'Brien, M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 25
- Issue
- 7
- Pages
- 1270-1283
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2152327189
- Cited by
- 182
- References
- 87
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.